Skip to main content
Boston Scientific Corporation (BSX)
NYSE: BSX · Real-Time Price · USD
90.17
-0.16 (-0.18%)
At close: Nov 20, 2024, 4:00 PM
89.86
-0.31 (-0.34%)
Pre-market: Nov 21, 2024, 7:18 AM EST

Boston Scientific Revenue

Boston Scientific had revenue of $4.21B in the quarter ending September 30, 2024, with 19.34% growth. This brings the company's revenue in the last twelve months to $15.91B, up 15.66% year-over-year. In the year 2023, Boston Scientific had annual revenue of $14.24B with 12.29% growth.

Revenue (ttm)
$15.91B
Revenue Growth
+15.66%
P/S Ratio
8.33
Revenue / Employee
$331,479
Employees
48,000
Market Cap
132.90B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202314.24B1.56B12.29%
Dec 31, 202212.68B794.00M6.68%
Dec 31, 202111.89B1.98B19.92%
Dec 31, 20209.91B-822.00M-7.66%
Dec 31, 201910.74B912.00M9.28%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Pfizer 59.38B
Sanofi 54.03B
Bristol-Myers Squibb Company 47.44B
Medtronic 33.00B
Amgen 32.53B
Gilead Sciences 28.30B
Danaher 23.74B
Stryker 21.97B
Revenue Rankings

BSX News

More News